Perrigo Company plc

$ 10.17 -0.18 %

Perrigo Company plc is dedicated to delivering over-the-counter (OTC) health and wellness products designed to enhance personal well-being. The company's goal is to equip consumers with the means to proactively address or manage health conditions they can treat themselves. Its operations are organized into two key divisions: Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas division concentrates on the creation, production, promotion, and sale of store-brand self-care items throughout the United States, Mexico, Canada, and South America. This segment offers a broad spectrum of products, encompassing solutions for upper respiratory issues, pain relief and sleep assistance, digestive health, nutritional supplements (including vitamins and minerals), healthy lifestyle goods, skincare and personal hygiene products, and oral care. Notable brands within this portfolio include Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. Meanwhile, the Consumer Self-Care International division focuses on developing, manufacturing, marketing, and distributing its self-care brands to roughly 23 countries, primarily across Europe. These products reach consumers via an extensive network of pharmacies, wholesalers, drugstores, grocery retailers, and para-pharmacies. In addition to its proprietary offerings, Perrigo Company plc also provides contract manufacturing services. The company, established in 1887, has its global headquarters located in Dublin, Ireland.

CEO: Patrick Lockwood-Taylor - https://www.perrigo.com

Price objectif

-

Recommandation

Hold

DCF

$ 76.43

Loading data...

0Y5E.L vs S&P500

Loading data...

No data available.

Quick ratio

1.59

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

-12.43

may indicate that the company is undervalued or has poor growth prospects.

EPS

-0.82

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-50.65 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

3.37 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

4.96

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

1.52

means it relies more on debt, which can increase financial risk.

Free cash flow per share

0.78

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

-8.73 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
0.33 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.36 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.48 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.